Non-invasive genetic imaging for molecular and cell therapies of cancer

Clinical and Translational Oncology

Volumn 9, Issue 11, 2007, Pages 703-714

  Belmar, C ^a   So, P W ^b   Vassaux, G ^c   Moleiro San Emeterio, V ^a   Martin Duque P ^a  

^a UNIVERSIDAD FRANCISCO DE VITORIA   (Spain)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c INSERM   (France)

Author keywords

Bioluminescence; Imaging; MRI; PET; SPECT

Indexed keywords

3 (2 FLUOROETHYL)SPIPERONE; 5 BROMO 4 INDOLYLBETA DEXTRO GALACTOPYRANOSIDE; ADENOVIRUS VECTOR; ANTISENSE OLIGODEOXYNUCLEOTIDE; BETA GALACTOSIDASE; DOPAMINE 2 RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; FIALURIDINE; FLUORINE 18; FLUORODEOXYGLUCOSE F 18; GADOLINIUM CHELATE; GANCICLOVIR; GREEN FLUORESCENT PROTEIN; HESPES SIMPLEX VIRUS 1 THYMIDINE KINASE; LUCIFERASE; MANGAFODIPIR; PERTECHNETIC ACID TC 99M; PROTEIN P53; PYRANOSIDE; RADIOACTIVE IODINE; RADIOLABELLED ANTISENSE OLIGODEOXYNUCLEOTIDE; SODIUM IODIDE SYMPORTER; TECHNETIUM 99M; TELOMERASE REVERSE TRANSCRIPTASE; THYMIDINE KINASE; TRANSFERRIN RECEPTOR;

BIOLUMINESCENCE; CANCER GENE THERAPY; CELL TRANSPORT; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; GENE EXPRESSION REGULATION; GENETIC TRANSDUCTION; GENETIC TRANSFECTION; IMAGE ANALYSIS; IMAGE PROCESSING; INTERNALIZATION; ISOTOPE LABELING; MOLECULAR THERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PROMOTER REGION; RADIOSENSITIVITY; REPORTER GENE; REVIEW; RNA SPLICING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SPLICEOSOME; STEM CELL GENE THERAPY; TRANSGENE; VIRAL GENE DELIVERY SYSTEM; ANIMAL; CLINICAL TRIAL; DIAGNOSTIC IMAGING; DISEASE MODEL; GENETICS; HUMAN; METHODOLOGY; NEOPLASM;

ANIMALS; CLINICAL TRIALS AS TOPIC; DIAGNOSTIC IMAGING; DISEASE MODELS, ANIMAL; HUMANS; NEOPLASMS;

EID: 39749190051     PISSN: 1699048X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12094-007-0127-z     Document Type: Review

References (99)

1. Cui Y, Golob J, Kelleher E et al (2002) Targeting transgene expression to antigen-presenting cells derived from lentivirus-transduced engrafting human hematopoietic stem/progenitor cells. Blood 99:399-408
2. Tjuvajev JG, Stockhammer G, Desai R et al (1995) Imaging the expression of transfected genes in vivo. Cancer Res 55:6126-6132
3. Green LA, Yap CS, Nguyen K et al (2001) Indirect monitoring of endogenous gene expression by Positron Emission Tomography (PET) imaging of reporter gene expression in transgenic mice. Mol Imag Biol 4:71-81
4. Jacobs A, Voges J, Reszka R et al (2001) Positron-emission tomography of vector-mediated gene expression in gene therapy for gliomas. Lancet 358:727-729
5. Liang Q, Satyamurthy N, Barrio JR et al (2001) Noninvasive, quantitative imaging in living animals of a mutant dopamine D2 receptor reporter gene in which ligand binding is uncoupled from signal transduction. Gene Ther 8:1490-1498
6. Benali N, Cordelier P, Calise D et al (2000) Inhibition of growth and metastatic progression of pancreatic carcinoma in hamster after somatostatin receptor subtype 2 (sst2) gene expression and administration of cytotoxic somatostatin analog AN-238. Proc Natl Acad Sci U S A 97:9180-9185
7. DePuey EG (1996) New applications of myocardial perfusion imaging. Tex Heart Inst J 23:2
8. Gambhir S, Czernin J, Schwimmer J et al (2001) A tabulated summary of the FDG-PET literature. J Nucl Med 42:1S-71S
9. Elion GB (1993) Acyclovir: Discovery, mechanism of action, and selectivity. J Med Virol [Suppl 1]:2-6
10. Banerjee D (1999) Technology evaluation: Gene therapy (mesothelioma), NCI. Curr Opin Mol Ther 1:517-520
11. Tjuvajev JG, Avril N, Oku T et al (1998) Imaging herpes virus thymidine kinase gene transfer and expression by positron emission tomography. Cancer Res 58:4333-4341
12. Bennett JJ, Tjuvajev J, Johnson P et al (2001) Positron emission tomography imaging for herpes virus infection: Implications for oncolytic viral treatments of cancer. Nat Med 7:859-863
13. Hackman T, Dubrovin M, Balatoni J et al (2002) Monitoring E. coli cytosine deaminase gene expression by noninvasive imaging of the HSV-1-tk marker gene: Potential clinical applications in cancer gene therapy. Mol Imaging 1:36-42
14. Vassaux G, Martín-Duque P (2004) Use of suicide genes for cancer gene therapy: Study of the different approaches. Expert Opin Biol Ther 4: 519-530
15. Qiao J, Doubrovin M, Sauter BV et al (2002) Tumor-specific transcriptional targeting of suicide gene therapy. Gene Ther 9:168-175
16. Hackman T, Doubrovin M, Balatoni J et al (2002) Imaging expression of cytosine deaminase-herpes virus thymidine kinase fusion gene (CD/TK) expression with [124I]FIAU and PET. Mol Imaging 1:36-42
17. McLaren DC, Gambhir SS, Satyamurthy N et al (1999) Repetitive, non-invasive imaging of the dopamine D2 receptor as a reporter gene in living animals. Gene Ther 6:785-791
18. Liang Q, Satyamurthy N, Barrio JR et al (2001) Noninvasive, quantitative imaging in living animals of a mutant dopamine D2 receptor reporter gene in which ligand binding is uncoupled from signal transduction. Gene Ther 8:1490-1498
19. Gambhir SS, Herschman HR, Cherry SR et al (2000) Imaging transgene expression with radionuclide imaging technologies. Neoplasia 2:118-138
20. Bogdanov AA, Lewin M, Weissleder R (1999) Approaches and agents for imaging the vascular system. Adv Drug Deliv Rev 37:279-293
21. Schellingerhout D, Rainov NG, Breakefield XO, Weissleder R (2000) Quantitation of HSV mass distribution in a rodent brain tumor model. Gene Ther 7:1648-1655
22. Zinn KR, Chaudhuri TR (2002) The type 2 human somatostatin receptor as a platform for reporter gene imaging. Eur J Nucl Med Mol Imaging 29:388-399
23. Doubrovin M (2001) Imaging transcriptional regulation of p53-dependent genes with positron emission tomography in vivo. Proc Natl Acad Sci U S A 98:9300-9305
24. Groot-Wassink T, Aboagye EO, Wang Y et al (2004) Noninvasive imaging of the transcriptional promoter fragments in mice. Cancer Res 64:4906-4911
25. Merron A, Peerlinck I, Martín-Duque P et al (2007) SPECT/CT imaging of oncolytic adenovirus propagation in tumours in vivo using the Na/I symporter as a reporter gene. Gene Therapy (in press)
26. Benaron DA, Contag RR, Contang CH (1997) Imaging brain structure and function, infection and gene expression in the body using light. Philos Trans R Soc Lond B Biol Sci 352:755-761
27. Contag CH, Spilman SD, Contag PR et al (1997) Visualizing gene expression in living mammals using a bioluminescent reporter. Photochem Photobiol 66:523-531
28. Contag CH, Bachman MH (2002) Advances in vivo bioluminescence imaging of gene expression. Annu Rev Biomed Eng 4:235-260
29. Ray P, De A, Min JJ et al (2004) Imaging tri-fusion multimodality reporter gene expression in living subjects. Cancer Res 64:1323-1330
30. Contag CH, Contag PR, Mullins JI et al (1995) Photonic detection of bacterial pathogens in living hosts. Mol Microbiol 18:593-603
31. Lockley M, Fernandez M, Wang Y et al (2006) Activity of the adenoviral E1A deletion mutant dl922-947 in ovarian cancer: Comparison with E1A wild-type viruses, bioluminescence monitoring, and intraperitoneal delivery in Icodextrin. Cancer Res 66:990-998
32. Rehemtulla A, Stegman LD, Cardozo SJ et al (2000) Rapid and quantitative assessment of cancer treatment response using in vivo bioluminescence imaging. Neoplasia 2:491-495
33. Edinger M, Sweeney TJ, Tucker AA et al (1999) Noninvasive assessment of tumor cell proliferation in animal models. Neoplasia 1:303-310
34. Edinger M, Cao YA, Hornig YS et al (2002) Advancing animal models of neoplasia through in vivo bioluminescence imaging. Eur J Cancer 38:2128-2136
35. Wetterwald A, van der Pluijm G, Que I et al (2002) Optical imaging of cancer metastasis to bone marrow: A mouse model of minimal residual disease. Am J Pathol 160:1143-1153
36. Shah K, Tang Y, Breakefield XO, Weissleder R (2003) Real-time imaging of TRAIL-induced apoptosis of glioma tumors in vivo. Oncogene 22:6865-6872
37. Shah K, Jacobs A, Breakefield XO, Weissleder R (2004) Molecular imaging of gene therapy for cancer. Gene Ther 11:1175-1187
38. Modo M, Hoehn M, Bulte JW (2005) Cellular MR imaging. Mol Imaging 4:143-164
39. Weissleder R, Cheng HC, Bogdanova A, Bogdanova A Jr (1997) Magnetically labeled cells can be detected by MR imaging. J Magn Reson Med Imag 7:258-263
40. Franklin RJ, Blaschuk KL, Bearchell MC et al (1999) Magnetic resonance imaging of transplanted oligodendrocyte precursors in the rat brain. Neuroreport 10:3961-3965
41. de Vries IJM, Lesterhuis JW, Barentsz JO et al (2005) Magnetic resonance tracking of dendritic cells in melanoma cells for monitoring cellular therapy. Nat Biotechnol 23:1407-1413
42. Bulte JW, Ma LD, Magin R et al (1993) Selective MR imaging of labelled human peripheral blood mononuclear cells by liposome mediated incorporation of dextran-magnetite particles. Magn Reson Med 29:32-37
43. Josephsen L, Tung CH, Moore A, Weissleder R (1999) High efficiency intracellular magnetic labelling with novel superparamagnetic-Tat peptide conjugates. Bioconjug Chem 10:186-191
44. Bulte JWM, Zhang S, van Gelderen P et al (1999) Neurotransplantation of magnetically labelled oligodendrocyte progenitors: Magnetic resonance tracking of cell migration and myelination. Proc Natl Acad Sci U S A 96:15256-15261
45. Wilhelm C, Billotey C, Roger J et al (2003) Intracellular uptake of anionic superparamagnetic nanoparticles as a function of their surface coating. Biomaterials 24:1001-1011
46. Frank JA, Zywicke H, Jordan EK et al (2002) Magnetic intracellular labeling of mammalian cells by combining (FDA-approved) superparamagnetic iron oxide MR contrast agents and commonly used transfection agents. Acad Radiol 9:S484-488
47. Daldrup-Link HE, Rudellus M, Oostendorp RA et al (2003) Targeting of haematopoetic progenitor cells with MR contrast agents. Radiology 228:760-767
48. Giesel FL, Stroick M, Griebe M et al (2006) Gadofluorine M uptake in stem cells as a new magnetic resonance imaging tracking method. Invest Radiol 41:868-873
49. Hoehn M, Kustermann E, Blunk J et al (2002) Monitoring of implanted stems cell migration in vivo: A highly resolved in vivo magnetic resonance imaging investigation of experimental stroke in rat. Proc Natl Acad Sci U S A 99: 16267-16272
50. Shapiro EM, Skrtic S, Sharer K et al (2004) MRI detection of single particles for cellular imaging. Proc Natl Acad Sci U S A 101:10901-10906.
51. Navon G, Panigel R, Valensin G (1986) Liposomes containing paramagnetic macromolecules as MRI contrast agents. Magn Reson Med 3: 876-880
52. Pirko I, Johnson A, Ciric B et al (2004) In vivo magnetic resonance imaging of immune cells in the central nervous system with superparamagnetic antibodies. FASEB J 18:179-182
53. Moore A, Medarova Z, Potthast A, Dai G (2004) In vivo targeting of underglycosylated MUC-1 tumor antigen using a multimodal imaging probe. Cancer Res 64:1821-1827
54. Bulte JW, Hoekstra Y, Kamman RL et al (1992) Specific MR imaging of human lymphocytes by monoclonal antibody-guided dextran-magnetite particles. Magn Reson Med 25:148-157
55. So PW, Kalber T, Herlihy AH, Bell JD (2006) Chemical biotinylation of cells for molecular imaging and cell tracking. Proc Int Soc Mag Med 14:1870
56. Räty JR, Liimatainen T, Wirth T et al (2006) Magnetic resonance imaging of viral particle biodistribution in vivo. Gene Therapy 13:1440
57. Allen M, Bulte JWM, Liepold L et al (2005) Paramagnetic viral nanoparticles as potential high-relaxivity magnetic resonance contrast agents. Magn Reson Med 54:807
58. Anderson EA, Isaacman S, Peabody DS et al (2006) Viral nanoparticles donning a paramagnetic coat: Conjugation of MRI contrast agents to the MS2 capsid. Nano Lett 6:1160
59. Mulder JW, Strijkers GJ, Habets JW et al (2005) MR molecular imaging and fluorescence microscopy for identification of activated tumor endothelium using a bimodal lipidic nanoparticle. FASEB J 19:2008
60. Kang HW, Josephsen L, Petrovsky A et al (2002) Magnetic resonance imaging of inducible E-selectin expression in human endothelial cell culture. Bioconjug Chem 13:122
61. Kang HW, Torres D, Wald L et al (2006) Targeted imaging of human endothelial-specific marker in a model of adoptive cell transfer. Lab Invest 86:599
62. Sipkins DA, Cheresh DA, Kazemi MR et al (1998) Detection of tumor angiogenesis in vivo by alphavbeta3-targeted magnetic resonance imaging. Nat Med 4:623
63. Weissleder R, Moore A, Mahmood U et al (2000) In vivo magnetic resonance imaging of transgene expression. Nat Med 6:351
64. Ichikawa T, Högemann D, Saeki Y et al (2002) Free content MRI of transgene expression: Correlation to therapeutic gene expression. Neoplasia 4:523-530
65. Genove G, DeMarco U, Xu H et al (2005) A new transgene reporter for in vivo magnetic resonance imaging. Nat Med 11:450-454
66. Cohen B, Dafni H, Meir G et al (2005) Ferritin as an endogenous MRI reporter for noninvasive imaging of gene expression in C6 glioma tumors. Neoplasia 7:109-117
67. Louie AY, Hüber MM, Ahrens ET et al (2000) In vivo visualization of gene expression using magnetic resonance imaging. Nat Biotech 18:321-325
68. Zhao M, Kircher MF, Josephson L, Weissleder R (2002) Differential conjugation of Tat peptide to superparamagnetic nanoparticles and its effect on cellular uptake. Bioconjug Chem 13:840-844
69. Weissleder R, Simonva M, Bogdanova A et al (1997) MR imaging and scintigraphy of gene expression through melanin induction. Radiology 204:425-429
70. Riley PA (2003) Melanogenesis and melanoma. Pigment Cell Res 16:548-552
71. Alfke H, Stoppler H, Nockern F et al (2003) In vitro MR imaging of regulated gene expression. Radiology 228:488-492
72. So PW, Hotee S, Herlihy AH, Bell JD (2005) Generic method for imaging transgene expression. Magn Reson Med 54:218-221
73. Tannous BA, Grimm J, Perry KF et al (2006) Metabolic biotinylation of cell surface receptors for in vivo imaging. Nat Methods 3:391-396
74. Madio D, Van-Gelderen P, DesPres D et al (1998) Invited. On the feasibility of MRI-guided focused ultrasound for local induction of gene expression. J Magn Reson Imaging 8:101-104
75. Tang M, Redemann C, Szoka F (1996) In vitro gene delivery by degraded polyamidoamine dendrimers. Bioconjug Chem 7:703-714
76. Qui B, El-Sharkawy AM, Paliwal V et al (2004) Simultaneous radiofrequency (RF) heating and magnetic resonance (MR) thermal mapping using an intravascular MR imaging/RF heating system. Magn Reson Med 54:226-230
77. Gao F, Qiu B, Kar S et al (2006) Intravascular magnetic resonance/ radiofrequency may enhance gene therapy for prevention of in-stent neointimal hyperplasia. Acad Radiol 13:526-530
78. Yang X, Atalar E, Li D et al (2001) Magnetic resonance imaging permits in vivo monitoring of catheter-based vascular gene delivery. Circulation 104:1588-1590
79. Lawrie A, Brisken A, Francis S et al (1999) Ultrasound enhances reporter gene expression after transfection of vascular cells in vitro. Circulation 99:2617-2620
80. Ernst S, Ouyang F, Linder C et al (2004) Initial experience with remote catheter ablation using a novel magnetic navigation system: Magnetic remote catheter ablation. Circulation 109:1472-1475
81. Thornton AS, Janse P, Theuns DA et al (2006) Magnetic navigation in AV nodal re-entrant tachycardia study: Early results of ablation with one-and three-magnet catheters. Europace 8:225-230
82. Tallheden T, Nannmark U, Lorentzon M et al (2006) In vivo MR imaging of magnetically labeled human embryonic stem cells. Life Sci 79:999-1006
83. Arbab AS, Jordan EK, Wilson LB et al (2004) In vivo trafficking and targeted delivery of magnetically labeled stem cells. Hum Gene Ther 15: 351-360
84. Fodor PJ, Tomashefsky P, Funk C (1957) Enzyme levels in the growing and spontaneously regressing Flexner-Jobling carcinoma. II. ATPase and glycolysis. Arch Biochem Biophys 71(2): 403-413
85. Wang S, Mintz A, Mochizuki K et al (2007) Multimodality optical imaging and 18F-FDG uptake in wild-type p53-containing and p53-null human colon tumor xenografts. Cancer Biol Ther 6(10) (in press)
86. Kettunen MI, Gröhn OHJ (2005) Tumour gene therapy monitoring using magnetic resonance imaging and spectroscopy. Current Gene Ther 5:685-696
87. Walter G, Cordier L, Bloy D, Sweeney HL (2005) Noninvasive monitoring of gene correction in dystrophic muscle. Magn Reson Med 54: 1369-1376
88. Phelps ME (2000) Inaugural article: Positron emission tomography provides molecular imaging of biological processes. Proc Natl Acad Sci USA 97:9226-9233
89. Phelps ME (2000) PET: The merging of biology and imaging into molecular imaging. J Nucl Med 41:661-681
90. Gulec SA, Hoenie E, Hostetter R, Schwartzentruber D (2007) PET probe-guided surgery: Applications and clinical protocol. World J Surg Oncol 5:65
91. Blasberf RG, Tjuvajev JG (2003) Molecular-genetic imaging: Current and future perspectives. J Clin Invest 111:1620-1629
92. Serganova I, Ponomarev V, Blasberg R (2007) Human reporter genes: potential use in clinical studies. Nucl Med Biol 34:791-807
93. Chao H, Mansfield SG, Bartel RC et al (2003) Phenotype correction of hemophilia A mice by spliceosome-mediated RNA trans-splicing. Nat Med 9:1015-1019
94. Liu X, Jiang Q, Mansfield SG et al (2002) Partial correction of endogenous DeltaF508 CFTR in human cystic fibrosis airway epithelia by spliceosome-mediated RNA trans-splicing. Nat Biotechnol 20:47-52
95. Bhaumik S, Walls Z, Puttaraju M et al (2004) Molecular imaging of gene expression in living subjects by spliceosome-mediated RNA transsplicing. Proc Natl Acad Sci U S A 23:8693-8698
96. Söling A, Simm A, Rainov NG (2002) Intracellular localization of Herpes simplex virus type I thymidine kinase fused to different fluorescent proteins depends on choice of fluorescent tag. FEBS Lett 527:153-158
97. Ray P, Wu AM, Gambhir SS (2003) Optical bioluminescence and positron emission tomography imaging of a novel fusion reporter gene in tumor xenografts of living mice. Cancer Res 63:1160-1165
98. Ponomarev V, Doubrovin M, Serganova I et al (2004) A novel triple-modality reporter gene for whole-body fluorescent, bioluminescent and nuclear non-invasive imaging. Eur J Nucl Med Mol Imaging 31:740-751
99. Ray P, De A, Min JJ et al (2004) Imaging tri-fusion multimodality reporter gene expression in living subjects. Cancer Res 64:1323-1330